Alkermes Plc reports results for the quarter ended in December - Earnings Summary

Alkermes

15/02/2024 14:32

* Alkermes Plc  ALKS.OQ  reported quarterly adjusted
earnings of
22 cents​​ per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of 14 cents.  The mean expectation of ten analysts for the
quarter was for earnings of 51 cents per share. Wall Street
expected results to range from 43 cents to 60 cents per share.
    * Revenue rose 74.7% to $377.48 million from a year ago;
analysts
expected $362.02 million. 
    * Alkermes Plc's reported EPS for the quarter was 66 cents​.
    * The company reported quarterly net income of $112.78
million.
    * Alkermes Plc shares had risen by 0.9% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days, three analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Alkermes Plc is
$34.00 
This summary was machine generated from LSEG data February 15 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.51           0.22           Missed
 Sep. 30 2023      0.44           0.64           Beat
 Jun. 30 2023      0.46           0.55           Beat
 Mar. 31 2023      -0.01          0.01           Beat